Related Experiment Videos
3-Hydroxy-3-methylglutaryl coenzyme A lyase deficiency. Follow-up of first described case
Acta Paediatrica Scandinavica
|March 1, 1981
Insights
A child with 3-hydroxy-3-methylglutaryl Coenzyme A lyase deficiency, a leucine metabolism defect, is developing well. Strict dietary leucine control is crucial due to high sensitivity.
Area of Science:
- Biochemistry
- Metabolic disorders
- Genetics
Background:
- Leucine metabolism is essential for normal physiological function.
- Deficiencies in key metabolic enzymes can lead to severe health issues.
- 3-hydroxy-3-methylglutaryl Coenzyme A lyase (HMGCL) deficiency is a rare inborn error of metabolism.
Observation:
- A pediatric case initially suspected in 1976 at 7 months of age.
- The patient is now 4 years and 7 months old.
- Clinical follow-up indicates satisfactory physical and developmental progress.
Findings:
- The patient exhibits a confirmed biochemical defect in leucine metabolism.
- The metabolic abnormality stems from a deficiency in 3-hydroxy-3-methylglutaryl Coenzyme A lyase activity.
- The condition demonstrates extreme sensitivity to dietary leucine intake.
Implications:
- Effective management requires meticulous dietary leucine restriction.
- Long-term monitoring is essential for children with HMGCL deficiency.
- Understanding leucine metabolism defects informs therapeutic strategies for inborn errors of metabolism.
Abstract:
We report the progress of a child with a defect in leucine metabolism due to a deficiency of 3-hydroxy-3-methylglutaryl Coenzyme A lyase activity. This child was reported briefly in 1976 when the abnormality was first suspected at which time he was 7 months old. He is now aged 4 years 7 months and appears to be well and developing satisfactorily. His diet has been difficult to control and the biochemical defect is extremely sensitive to small amounts of leucine in the diet.